Other languages Generation Bio Co.

Equities

GBIO

US37148K1007

Market Closed - Nasdaq Other stock markets 16:00:00 2024-04-26 EDT			5-day change	1st Jan Change
2.9 ^USD	-3.65%		+3.57%	+75.76%

04-12	Transcript : Generation Bio Co. - Special Call
03-07	Needham Cuts Price Target on Generation Bio to $10 From $14, Maintains Buy Rating	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Generation Bio Co. Reports Earnings Results for the Full Year Ended December 31, 2023	03-06
Generation Bio Co. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-06
Generation Bio Insider Bought Shares Worth $124,778, According to a Recent SEC Filing	12-05
Generation Bio to Lay Off 40% of Staff in Bid to Extend Cash Runway Into H2 2027	11-29
Generation Bio Co. Announces Termination of Executives, Effective on January 28, 2024	11-29
Generation Bio Co. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09
Generation Bio Co. Announces Demonstration of Highly Selective T Cell Transduction in Vivo with Cell-Targeted Lnp Platform	23-10-26
Generation Bio Co. Announces Breakthrough in Its Non-Viral Genetic Medicine Platform with Novel "Immune-Quiet" Dna	23-10-18
Generation Bio Co. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-02
Generation Bio Co. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10
Generation Bio Co., Appoints Yalonda Howze, J.D., as Chief Legal Officer and Secretary	23-04-05
Moderna : collaboration 'stratégique' avec Generation Bio	23-03-24
Sector Update: Health Care Stocks Mixed During Late Afternoon	23-03-23
Moderna, Generation Bio Working Together to Develop Non-Viral Genetic Medicines	23-03-23
Moderna, Inc. and Generation Bio Co. Announce Strategic Collaboration to Develop Non-Viral Genetic Medicines	23-03-23
Generation Bio Co. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-02-23
Generation Bio Co. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-23
Generation Bio Co. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-03
Generation Bio Co. Names Phillip Samayoa as Chief Strategy Officer	22-09-20
Insider Buy: Generation Bio	22-09-19

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Generation Bio Co.

Equities

GBIO

US37148K1007

Other languages

Filters